HISTONE DEACETYLASE INHIBITOR

Clinical trials for HISTONE DEACETYLASE INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new HISTONE DEACETYLASE INHIBITOR trials appear

Sign up with your email to follow new studies for HISTONE DEACETYLASE INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for tough bladder cancers: testing a Two-Drug attack

Disease control Not yet recruiting

This study is testing whether adding a drug called entinostat to standard chemotherapy can help control advanced bladder cancer that has stopped responding to initial treatment. It will involve about 29 patients whose cancer cannot be surgically removed and has spread. The main g…

Matched conditions: HISTONE DEACETYLASE INHIBITOR

Phase: PHASE1, PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

HISTONE DEACETYLASE INHIBITOR

Get alerted when new HISTONE DEACETYLASE INHIBITOR trials appear

New hope for tough bladder cancers: testing a Two-Drug attack